JW THERAP-B (02126.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec8

JWCTAR201 IIT Research Data Released by Juno Therapeutics-B

09:42

Dec7

5 CAR-T Cell Therapy Products Included in the First Batch of Commercial Insurance Innovative Drug Catalog

03:17

Nov2

Yumeng Juno's CAR-T Cell Drug Aims for Inclusion in Commercial Insurance Innovative Drug Catalog

09:34

Oct21

JW Therapeutics Submits First-in-Human Phase I Data for Relmacabtagene Autoleucel

08:35

Oct9

JW Therapeutics' Relmacabtagene Ablamelical (Relma-Cel) Supplemental Application for Domestic Slow Virus Vector Approved for Filing by NMPA

09:00

Sep3

CICC Raises JUNO Therapeutics' Target Price to HKD 6.04

02:47

Schedules & Filings

Schedules

Filings

Aug27

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 58.2 M, Net Income -146.26 M, EPS -0.3519

Mar27

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 37.98 M, Net Income -186.36 M, EPS -0.4499

Aug28

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 46.64 M, Net Income -129.09 M, EPS -0.3124

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change